MedPath

Diffusion MRI and Growth Plate Injuries: Pilot Study

Conditions
Fracture
Registration Number
NCT01774539
Lead Sponsor
University of British Columbia
Brief Summary

Children who suffer fractures to the growth plates (physes) of their bones are at risk for premature growth arrest which can lead to long term complications. There is currently no technique to predict who is at risk of growth arrest following a physeal injury. The investigators aim to determine if diffusion MRI (an imaging method to analyze tissue properties) can effectively pick up differences between a healthy growth plate and an injured one. This would allow orthopaedics surgeons to predict which injuries are at a higher risk of growth arrest, so earlier interventions can be done in the orthopaedic clinic.

Detailed Description

The purpose of this study is to determine if diffusion MRI can be used for tissue characterization in childhood and adolescent growth plate injuries, and to get a better understanding of the physiologic disturbance of an injured physis

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
10
Inclusion Criteria
  • Salter-Harris Type II, III, or IV fracture through the distal radius
  • Growth plates are open
  • Ages 8-12
  • Able to consent in English
Exclusion Criteria
  • All fractures not sustained to distal radius
  • SH Type I or V fracture
  • Injury to contralateral limb
  • Previous injury to distal radius
  • Diseases known to alter bone healing or growth]
  • Contraindications to undergoing an MRI scan

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Tissue characterization of growth plate using diffusion MRI4-6 weeks following injury

Diffusion MRI scan of injured and contralateral (control) physis.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

British Columbia Children's Hospital

🇨🇦

Vancouver, British Columbia, Canada

British Columbia Children's Hospital
🇨🇦Vancouver, British Columbia, Canada
Sameer Desai
Contact
604-875-2359
sameer.desai@cw.bc.ca
Firoz Miyanji, MD, FRCSC
Principal Investigator
Kishore Mulpuri, MBBS, MS, MHSc
Sub Investigator
Chris Reilly, MD, FRCSC
Sub Investigator
Ken Poskitt, MDCM
Sub Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.